CP has been used as an important component in the treatment of breast cancer (Xu et al., 2024), gastric cancer (Xu J. et al., 2023), and non-small cell lung cancer (Hao et al., 2015) for many years as an adjuvant therapy (Chen G. et al., 2024). This evidence concerns the gene CP and gastric cancer.